11 Nov by Vitaliy Dadalyan Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) 14% ROE Worse Than Average? Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is…
